"The voice of oncology in Massachusetts."

Coherus BioSciences' Single-Dose (6mg/0.6mL), Prefilled Autoinjector Presentation of UDENYCA® (pegfilgrastim-cbqv) is Now Available in US

May 22, 2023 2:12 PM | Katy Monaco (Administrator)

Coherus BioSciences, Inc., today announced that the single-dose (6mg/0.6mL), prefilled autoinjector presentation of UDENYCA┬« (pegfilgrastim-cbqv) is now available for commercial sale in the United States.  Read More.

Massachusetts Society of Clinical Oncologists ┬ę2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software